CRISPR May Consider IPOCRISPR, crispr genome editing system | CRISPR, crispr genome editing system

Home » News » CRISPR May Consider IPO

Rodger Novak, Chief Executive Officer of CRISPR Therapeutics AG said, ” Crispr Therapeutics would consider an IPO in 2016.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>